Research ID
hum0422-v1Release info
Research title
Multi-institutional observational study to elucidate the pathogenesis of endometrial carcinoma through integrated genomic analysis
Research overview
- Aims
- Endometrial cancer (EC) incidence is rising, emphasizing the need for advancements in prevention and treatment. Type I ECs have endometrioid carcinoma G1/G2 histology and depend on estrogen, while Type II ECs occur post-menopause and are estrogen-independent. Genomic analysis has identified four subtypes: ultra-mutated (POLE mutation), hypermutated (microsatellite instability), copy-number low, and copy-number high groups. However, the relationship between tumor histopathology and the genomic classification needs further clarification. To develop effective prevention and treatment, we aim to understand EC's carcinogenesis and etiology.
- Methods
- Whole exome sequencing, RNA sequencing
- Participants/materials
- 89 ECs
- URL
- N/A
Datasets
| Cart | Dataset ID | Type of data | Analysis method | Access criteria | Date published |
|---|---|---|---|---|---|
| JGAD000894 | NGS (Exome, RNA-seq) |
| Controlled-access (Type I) | 2026-03-31 |
Data provider
- Principal investigator
- Masahito Kawazu
- Affiliation
- Division of Cell Therapy, Chiba Cancer Center Research Institute
Research projects
No research projects.
Grants
| Name | Title | Project number |
|---|---|---|
The Uehara Memorial Foundation (2022) | Genomic Alterations Driving Immune Evasion in Endometrial Cancer | N/A |
Related publications
No related publications.
Controlled access users
| Principal investigator | Affiliation | Country/Region | Research title | Period of data use | Dataset ID |
|---|---|---|---|---|---|
| Hitoshi Iuchi | Waseda Research Institute for Science and Engineering, Waseda University | Japan | A comprehensive understanding of cancer through multi-omics analysis | 2026-09-07 – 2029-07-31 | |
| Michihiro Tanikawa | Department of obstetrics and gynecology, The University of Tokyo Hospital | Japan | Molecular Biological Analysis of Abnormalities Involved in the Development and Prognosis of Endometrial Cancer, Uterine Sarcoma, and Endometrial Hyperplasia | 2026-09-07 – 2030-03-31 |